newsfilter
← Latest News
ACCESS Newswire·

CASI Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Business and Financial Results

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. , , a Cayman incorporated biopharmaceutical company focused on developing and